Clinical trial

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

NCT03405168

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-01-01

PhasePHASE2

Study timeline

Study start (actual)2018-01-01Date precision: day

Registry last updated2018-11-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Breast Cancerunresolved

Antibioticunresolved

Stable Disease With a Trend of Progressionunresolved

Interventions

Moxifloxacin Hydrochloride 400mg TabletDRUG

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03405168 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.